Alison L. Hannah
DirectoratNeogenomics· In proxies 2023–2025
Alison L. Hannah sits on 2 public boards.
Experience
- NeogenomicsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +98%
- Rigel PharmaceuticalsPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Rigel PharmaceuticalsPublic company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?